.jpg)
Researchers at the University of Colorado Anschutz Medical Campus are part of an international team that has discovered a molecular signature that plays a pivotal role in sustaining the activation of immune cells in chronic neurological diseases, including progressive multiple sclerosis (MS).
Research Patient Care Multiple Sclerosis (MS)
Multiple sclerosis, or MS, affects several million people worldwide, with Colorado claiming one of the highest rates in the country. About one in 360 people in our state has MS, and women with the disease outnumber men by about three to one. Most often diagnosed between the ages 20 to 40, MS generally strikes patients during the prime of life.
Clinical Research Autoimmune disease Multiple Sclerosis (MS)
University of Colorado Anschutz Medical Campus researchers are part of an international team that has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.
Research Patient Care Autoimmune disease Multiple Sclerosis (MS)
A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, PhD, senior author of a new study on plasma immunoglobulin G (IgG) antibody aggregates.
Laura Kelley
